TFAP4 inhibits differentiation of MYCN-amplified neuroblastoma

被引:0
|
作者
Zhang, Shuobo [1 ]
Lopez, Gonzalo [1 ]
Yu, Jiyang [2 ]
Silva, Jose [3 ]
Kadenhe-Chiweshe, Angela [1 ]
Califano, Andrea [1 ]
Yamashiro, Darrell [1 ]
机构
[1] Columbia Univ, New York, NY USA
[2] Pfizer, New York, NY USA
[3] Mt Sainai Med Sch, New York, NY USA
关键词
D O I
10.1158/1538-7445.AM2015-2083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2083
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Aryl hydrocarbon receptor is a tumor promoter in MYCN-amplified neuroblastoma cells through suppression of differentiation
    Chaudhry, Kanita A.
    Jacobi, Justine J.
    Gillard, Bryan M.
    Karasik, Ellen
    Martin, Jeffrey C.
    Fernandes, Tatiane da Silva
    Hurley, Edward
    Feltri, Maria Laura
    Attwood, Kristopher M.
    Twist, Clare J.
    Smiraglia, Dominic J.
    Long, Mark D.
    Bianchi-Smiraglia, Anna
    ISCIENCE, 2023, 26 (11)
  • [22] A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
    Zhang, Hai-Feng
    Delaidelli, Alberto
    Javed, Sumreen
    Turgu, Busra
    Morrison, Taylor
    Hughes, Christopher S.
    Yang, Xiaqiu
    Pachva, Manideep
    Lizardo, Michael M.
    Singh, Gurdeep
    Hoffmann, Jennifer
    Huang, Yue Zhou
    Patel, Khushbu
    Shraim, Rawan
    Kung, Sonia H. Y.
    Morin, Gregg B.
    Aparicio, Samuel
    Martinez, Daniel
    Maris, John M.
    Bosse, Kristopher R.
    Williams, Karla C.
    Sorensen, Poul H.
    SCIENCE ADVANCES, 2023, 9 (34)
  • [23] Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
    Øyvind H. Hald
    Lotte Olsen
    Gabriel Gallo-Oller
    Lotta Helena Maria Elfman
    Cecilie Løkke
    Per Kogner
    Baldur Sveinbjörnsson
    Trond Flægstad
    John Inge Johnsen
    Christer Einvik
    Oncogene, 2019, 38 : 2800 - 2813
  • [24] Striking Dichotomy in Outcome of MYCN-Amplified Neuroblastoma in the Contemporary Era
    Kushner, Brian H.
    Modak, Shakeel
    Kramer, Kim
    LaQuaglia, Michael P.
    Yataghene, Karima
    Basu, Ellen M.
    Roberts, Stephen S.
    Cheung, Nai-Kong V.
    CANCER, 2014, 120 (13) : 2050 - 2059
  • [25] Exploit the zebrafish to study lymphocyte infiltration in MYCN-amplified neuroblastoma
    Qin, Xiaodan
    Lam, Andrew
    Feng, Hui
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [26] Inhibitors of Ribosome Biogenesis Repress the Growth of MYCN-Amplified Neuroblastoma
    Olsen, L.
    Hald, O.
    Gallo-Oller, G.
    Elfmann, L.
    Lokke, C.
    Kogner, P.
    Sveinbjornsson, B.
    Flaegstad, T.
    Johnsen, J. I.
    Eivik, C.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S337 - S337
  • [27] Telomerase-specific oncolytic adenovirotherapy targeting MYCN addiction in MYCN-amplified neuroblastoma
    Tanimoto, Terutaka
    Tazwa, Hiroshi
    Ieda, Takeshi
    Noso, Hiroshi
    Oyama, Takanori
    Urata, Yasuo
    Kagawa, Shunsuke
    Noda, Takuo
    Fujiwara, Toshiyoshi
    CANCER SCIENCE, 2018, 109 : 943 - 943
  • [28] A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
    Zhang, Hai-Feng
    Delaidelli, Alberto
    Javed, Sumreen
    Turgu, Busra
    Hughes, Christopher S.
    Yang, Xiaqiu
    Lizardo, Michael
    Martinez, Daniel
    Maris, John M.
    Bosse, Kristopher R.
    Williams, Karla C.
    Sorensen, Poul H.
    CANCER RESEARCH, 2023, 83 (07)
  • [29] In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells
    Kavallaris, M
    Gardaneh, M
    Cheung, B
    Camacho, ML
    Hocker, JE
    Norris, MD
    Haber, M
    Marshall, GM
    ANTICANCER RESEARCH, 1998, 18 (3A) : 1793 - 1797
  • [30] Targeted Inhibition of MYCN Synergizes With Current Chemotherapeutic Agents in MYCN-amplified Neuroblastoma Cells
    Montemurro, Luca
    Angelucci, Silvia
    Amadesi, Camilla
    Venturelli, Leonardo
    Fasci, Antonio
    Cantelli, Erika
    Toya, Serge Mbiandjeu
    Tortori, Andrea
    Scardovi, Anna Lisa
    Hrelia, Patrizia
    Pession, Andrea
    Tonelli, Roberto
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2014, 36 (04) : 325 - 326